OR-1855 是 Levosimendan 的活性代谢产物，对人体肌层收缩力有影响。Levosimendan 是一种钙敏感性药物，用于治疗急性失代偿性充血性心力衰竭。
货号:ajcx16296
CAS:101328-85-2
分子式:C11H13N3O
分子量：203.24
溶解度:Soluble in DMSO
纯度：98%
存储：Store at -20°C
库存：现货

Background:

OR-1855, an active metabolite of Levosimendan, has effect on human myometrial contractility. Levosimendan is a calcium sensitiser used in the management of acutely decompensated congestive heart failure[1][2].

[1]. Banfor PN, et al. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs. Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H238-48. [2]. Mark P. Hehir, et al. 487: OR-1855, a levosimendan metabolite with an effect on human myometrial contractility.December 2009Volume 201, Issue 6, Supplement, Pages S182-S183.